Therefore, even though it has been reported that APRI and CRP might be candidates as prognostic biomarkers in HCC, the clinical value of them in HCC were still inconsistent and debatable for many reasons, such as limited sample sizes. Here, CRP is linked to hepatocellular carcinoma.